Literature DB >> 27761834

How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.

Mandy Beyer1, Nicole Kiweler1, Siavosh Mahboobi2, Oliver H Krämer3.   

Abstract

Histone deacetylases (HDACs) catalyze the deacetylation of lysine residues in their target proteins. This biochemical modification can have profound effects on the functions of these proteins and a dysregulation of HDAC activity contributes to severe diseases, including neoplastic transformation. In the following chapter, we present a strategy that allows to distinguish between the inhibition of the class I HDACs HDAC1, 2, and 3 and of the class IIb HDAC HDAC6. This method is based on Western blot and relies on the detection of hyperacetylated substrates of class I or class IIb HDACs in lysates from cells that were treated with histone deacetylase inhibitors (HDACi).

Entities:  

Keywords:  Acetylation; HDAC6; HDACi; HDACs; Histone; Tubulin

Mesh:

Substances:

Year:  2017        PMID: 27761834     DOI: 10.1007/978-1-4939-6527-4_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracil.

Authors:  Nicole Kiweler; Helena Schwarz; Alexandra Nguyen; Stephanie Matschos; Christina Mullins; Andrea Piée-Staffa; Christina Brachetti; Wynand P Roos; Günter Schneider; Michael Linnebacher; Walburgis Brenner; Oliver H Krämer
Journal:  Cell Biol Toxicol       Date:  2022-05-24       Impact factor: 6.691

2.  Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.

Authors:  Patrik Zeyen; Yanira Zeyn; Daniel Herp; Fereshteh Mahmoudi; Talha Z Yesiloglu; Frank Erdmann; Matthias Schmidt; Dina Robaa; Christophe Romier; Johannes Ridinger; Corey J Herbst-Gervasoni; David W Christianson; Ina Oehme; Manfred Jung; Oliver H Krämer; Wolfgang Sippl
Journal:  Eur J Med Chem       Date:  2022-03-11       Impact factor: 6.514

3.  Human Platelet Lysate as Valid Cell Growth Additive to Assess Protein Acetylation.

Authors:  Miriam Pons; Roland Conradi; Walburgis Brenner; Oliver H Krämer
Journal:  Methods Mol Biol       Date:  2023

4.  Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line.

Authors:  Michael Gock; Christina S Mullins; Christine Harnack; Friedrich Prall; Robert Ramer; Anja Göder; Oliver H Krämer; Ernst Klar; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

5.  HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1.

Authors:  Mandy Beyer; Annette Romanski; Al-Hassan M Mustafa; Miriam Pons; Iris Büchler; Anja Vogel; Andrea Pautz; Andreas Sellmer; Günter Schneider; Gesine Bug; Oliver H Krämer
Journal:  Cancers (Basel)       Date:  2019-09-26       Impact factor: 6.639

6.  Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3.

Authors:  Vanessa Wachholz; Al-Hassan M Mustafa; Yanira Zeyn; Sven J Henninger; Mandy Beyer; Melanie Dzulko; Andrea Piée-Staffa; Christina Brachetti; Patricia S Haehnel; Andreas Sellmer; Siavosh Mahboobi; Thomas Kindler; Walburgis Brenner; Teodora Nikolova; Oliver H Krämer
Journal:  Arch Toxicol       Date:  2021-10-19       Impact factor: 5.153

7.  Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion.

Authors:  Alexandra Nguyen; Melanie Dzulko; Janine Murr; Yun Yen; Günter Schneider; Oliver H Krämer
Journal:  Cells       Date:  2021-09-23       Impact factor: 6.600

8.  Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells.

Authors:  Anke Rauch; Annemarie Carlstedt; Claudia Emmerich; Al-Hassan M Mustafa; Anja Göder; Shirley K Knauer; Michael Linnebacher; Thorsten Heinzel; Oliver H Krämer
Journal:  Oncotarget       Date:  2018-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.